Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,911.50p on 13-11-2026 at 19:35:09
Change 10.50p 0.55%
Buy 1,915.50p
Sell 1,915.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 199.00 at 1,911.50p
Day's Volume: 3,100,778
Last Close: 1,911.50p
Open: 1,897.50p
ISIN: GB00BN7SWP63
Day's Range 1,892.50p - 1,921.00p
52wk Range: 1,735.50p - 2,282.00p
Market Capitalisation: £76.63b
VWAP: 1,910.53512p
Shares in Issue: 4.01b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Higher Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 199 1,911.50p Automatic Execution
 16:37:56 - 13-Nov-26
Sell* 215 1,911.50p Automatic Execution
 16:37:56 - 13-Nov-26
Sell* 199 1,911.50p Automatic Execution
 16:37:56 - 13-Nov-26
Sell* 199 1,911.50p Automatic Execution
 16:37:56 - 13-Nov-26
Sell* 199 1,911.50p Automatic Execution
 16:37:56 - 13-Nov-26
Sell* 199 1,911.50p Automatic Execution
 16:37:56 - 13-Nov-26
Sell* 275 1,911.50p Automatic Execution
 16:37:56 - 13-Nov-26
Sell* 199 1,911.50p Automatic Execution
 16:37:56 - 13-Nov-26
Sell* 199 1,911.50p Automatic Execution
 16:37:56 - 13-Nov-26
Sell* 399 1,911.50p Automatic Execution
 16:37:56 - 13-Nov-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
13th Nov 2026 (Fri) 1,897.50 1,921.00 1,892.50 1,911.50 3,100,778
12th Nov 2026 (Thu) 1,910.00 1,918.00 1,889.00 1,901.00 4,344,937
11th Nov 2026 (Wed) 1,916.50 1,918.00 1,876.00 1,887.00 3,834,027
10th Nov 2026 (Tue) 1,923.50 1,944.50 1,915.50 1,917.00 4,847,188
9th Nov 2026 (Mon) 1,885.00 1,915.50 1,885.00 1,904.50 4,196,440
6th Nov 2026 (Fri) 1,870.50 1,890.00 1,828.50 1,890.00 6,698,040
5th Nov 2026 (Thu) 1,905.00 1,915.00 1,876.00 1,890.00 5,324,484
4th Nov 2026 (Wed) 1,815.50 1,895.50 1,802.00 1,890.00 10,738,509
3rd Nov 2026 (Tue) 1,835.00 1,848.00 1,827.00 1,827.50 5,019,111
2nd Nov 2026 (Mon) 1,831.50 1,845.50 1,824.50 1,824.50 5,438,653
30th Oct 2026 (Fri) 1,838.00 1,877.00 1,830.50 1,855.00 13,549,796
29th Oct 2026 (Thu) 1,790.00 1,842.50 1,790.00 1,814.00 9,351,620
28th Oct 2026 (Wed) 1,879.50 1,879.50 1,783.50 1,831.50 16,829,097
27th Oct 2026 (Tue) 1,907.00 1,925.50 1,902.50 1,923.50 3,982,525
26th Oct 2026 (Mon) 1,903.00 1,921.50 1,898.00 1,915.00 3,085,590
23rd Oct 2026 (Fri) 1,911.50 1,911.50 1,881.00 1,894.00 5,516,426
22nd Oct 2026 (Thu) 1,875.00 1,917.00 1,863.00 1,914.00 4,466,031
21st Oct 2026 (Wed) 1,863.50 1,884.00 1,856.50 1,868.00 11,052,161
20th Oct 2026 (Tue) 1,870.00 1,879.50 1,855.00 1,868.50 5,286,220
19th Oct 2026 (Mon) 1,871.00 1,871.00 1,851.00 1,855.00 4,924,273
16th Oct 2026 (Fri) 1,843.00 1,870.00 1,842.50 1,862.50 12,806,361
15th Oct 2026 (Thu) 1,823.50 1,876.50 1,812.00 1,868.50 12,523,051
14th Oct 2026 (Wed) 1,740.00 1,816.00 1,740.00 1,816.00 7,626,757
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
13th Nov 2026 7:00 am RNS Bexsero booster receives positive CHMP opinion
12th Nov 2026 3:30 pm RNS Director/PDMR Shareholding
6th Nov 2026 3:00 pm RNS GSK publishes provisional dividend dates
2nd Nov 2026 3:00 pm RNS Total Voting Rights
28th Oct 2026 7:00 am RNS 3rd Quarter Results
26th Oct 2026 3:30 pm RNS Director/PDMR Shareholding
26th Oct 2026 3:30 pm RNS Ris-Rez positive Ph 3 osteosarcoma data in China
26th Oct 2026 7:05 am RNS Jemperli data show 76% complete response rate
26th Oct 2026 7:00 am RNS Positive Mo-Rez Phase Ib data in ovarian cancer
21st Oct 2026 7:00 am RNS US FDA approves Hibsago for chronic hepatitis B
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

GSK gets support from EU panel for Meningitis B booster in adolescents

13th Nov 2026 08:37

(Alliance News) - GSK PLC on Friday said an EU advisory panel has recommended the use of Bexsero as a booster for older children who previously received the vaccine against Meningitis B. Read More

LONDON BRIEFING: Aviva on track; Landsec half-year profit jumps

13th Nov 2026 07:57

(Alliance News) - Aviva remains confident in its full-year outlook after growth in insurance premiums and wealth inflows, while Land Securities reports a sharp rise in half-year profit. GSK receives a positive European regulatory recommendation for a booster dose of its meningitis B vaccine. Read More

LONDON MARKET CLOSE: Stocks up but pound flags against dollar strength

11th Nov 2026 17:06

(Alliance News) - Stocks in London ended Wednesday in positive territory as technology stocks rallied, while the dollar continued to make progress after strong US inflation figures. Read More

LONDON BROKER RATINGS: DB raises Unilever; Investec raises Asos

11th Nov 2026 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

UK dividends calendar - next 7 days

5th Nov 2026 14:28

Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,902.56
Change39.47

Login to your account

Forgot Password?

Not Registered